GLRB is the third major gene of effect in hyperekplexia

47Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Glycinergic neurotransmission is a major inhibitory influence in the CNS and its disruption triggers a paediatric and adult startle disorder, hyperekplexia. The postsynaptic α1-subunit (GLRA1) of the inhibitory glycine receptor (GlyR) and the cognate presynaptic glycine transporter (SLC6A5/GlyT2) are well-established genes of effect in hyperekplexia. Nevertheless, 52% of cases (117 from 232) remain gene negative and unexplained. Ligand-gated heteropentameric GlyRs form chloride ion channels that contain the a1 and b-subunits (GLRB) in a 2α1:3β configuration and they form the predominant population of GlyRs in the postnatal and adult human brain, brainstem and spinal cord. We screened GLRB through 117 GLRA1- and SLC6A5-negative hyperekplexia patients using a multiplex-polymerase chain reaction and Sanger sequencing approach. The screening identified recessive and dominant GLRB variants in 12 unrelated hyperekplexia probands. This primarily yielded homozygous null mutations, with nonsense (n=3), small indel (n=1), a large 95 kb deletion (n=1), frameshifts (n 5 1) and one recurrent splicing variant found in four cases. A further three cases were found with two homozygous and one dominant GLRB missense mutations. We provide strong evidence for the pathogenicity of GLRB mutations using splicing assays, deletion mapping, cell-surface biotinylation, expression studies and molecular modelling. This study describes the definitive assignment of GLRB as the third major gene for hyperekplexia and impacts on the genetic stratification and biological causation of this neonatal/paediatric disorder. Driven principally by consanguineous homozygosity of GLRB mutations, the study reveals long-term additive phenotypic outcomes for affected cases such as severe apnoea attacks, learning difficulties and developmental delay. © The Author 2012. Published by Oxford University Press. All rights reserved.

References Powered by Scopus

Principles of activation and permeation in an anion-selective Cys-loop receptor

848Citations
N/AReaders
Get full text

Mutations in the α<inf>1</inf> subunit of the inhibitory glycine receptor cause the dominant neurologic disorder, hyperekplexia

465Citations
N/AReaders
Get full text

Identification of a gephyrin binding motif on the glycine receptor β subunit

361Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain

179Citations
N/AReaders
Get full text

The impact of human hyperekplexia mutations on glycine receptor structure and function

104Citations
N/AReaders
Get full text

Genetic neurological channelopathies: Molecular genetics and clinical phenotypes

90Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chung, S. K., Bode, A., Cushion, T. D., Thomas, R. H., Hunt, C., Wood, S. E., … Rees, M. I. (2013). GLRB is the third major gene of effect in hyperekplexia. Human Molecular Genetics, 22(5), 927–940. https://doi.org/10.1093/hmg/dds498

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

48%

Researcher 12

30%

Professor / Associate Prof. 9

23%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

41%

Agricultural and Biological Sciences 14

34%

Biochemistry, Genetics and Molecular Bi... 6

15%

Neuroscience 4

10%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free